(VIANEWS) – SPBK1 NORD-NORGE (NONG.OL), RYANAIR HOLD. PLC (RYA.IR), J.MARTINS,SGPS (JMT.LS) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. SPBK1 NORD-NORGE (NONG.OL)
59.4% sales growth and 11.29% return on equity
SpareBank 1 Nord-Norge provides banking services in Northern Norway. It operates through Retail Market, Corporate Market, Leasing, and Markets segments. The company offers mortgage, car, vehicle, and other loan related services. It also offers vehicle, home, travel, personal, and pet insurance services. In addition, the company provides various savings and pension related services, as well as debit and credit card services. Further, it offers financing, real estate leasing, agency, payment, and investment services. The company was founded in 1836 and is headquartered in Tromsø, Norway.
Earnings Per Share
As for profitability, SPBK1 NORD-NORGE has a trailing twelve months EPS of kr8.35.
PE Ratio
SPBK1 NORD-NORGE has a trailing twelve months price to earnings ratio of 11.43. Meaning, the purchaser of the share is investing kr11.43 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.29%.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 29.2% and 94.7%, respectively.
Sales Growth
SPBK1 NORD-NORGE’s sales growth is 26.2% for the current quarter and 59.4% for the next.
Revenue Growth
Year-on-year quarterly revenue growth declined by 7.9%, now sitting on 4B for the twelve trailing months.
Volume
Today’s last reported volume for SPBK1 NORD-NORGE is 73389 which is 54.16% below its average volume of 160111.
More news about SPBK1 NORD-NORGE.
2. RYANAIR HOLD. PLC (RYA.IR)
38.7% sales growth and 24.39% return on equity
Ryanair Holdings plc, together with its subsidiaries, provides scheduled-passenger airline services in Ireland, the United Kingdom, Italy, Spain, Germany, and other European countries. It is also involved in the provision of various ancillary services, such as non-flight scheduled and Internet-related services; in-flight sale of beverages, food, duty-free, and merchandise; and marketing of car hire and accommodation services, and travel insurance through its website and mobile app. In addition, the company offers aircraft and passenger handling, ticketing, and maintenance and repair services; and markets car parking, fast-track, airport transfers, attractions, and activities on its website and mobile app, as well as sells gift vouchers. As of June 30, 2022, it had a principal fleet of approximately 483 Boeing 737 aircrafts and 29 Airbus A320 aircrafts; and offered approximately 3,000 short-haul flights per day serving approximately 225 airports. Ryanair Holdings plc was founded in 1985 and is headquartered in Swords, Ireland.
Earnings Per Share
As for profitability, RYANAIR HOLD. PLC has a trailing twelve months EPS of €1.19.
PE Ratio
RYANAIR HOLD. PLC has a trailing twelve months price to earnings ratio of 12.47. Meaning, the purchaser of the share is investing €12.47 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 24.39%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
RYANAIR HOLD. PLC’s EBITDA is 1.73.
Moving Average
RYANAIR HOLD. PLC’s worth is higher than its 50-day moving average of €14.28 and way above its 200-day moving average of €12.85.
Revenue Growth
Year-on-year quarterly revenue growth grew by 57.3%, now sitting on 10.1B for the twelve trailing months.
More news about RYANAIR HOLD. PLC.
3. J.MARTINS,SGPS (JMT.LS)
21.9% sales growth and 24.27% return on equity
Jerónimo Martins, SGPS, S.A. operates in the food distribution and specialized retail sectors in Portugal, Poland, and Colombia. The company operates through Portugal Retail; Portugal Cash & Carry; Poland Retail; Colombia Retail; and Others, Eliminations and Adjustments segments. It operates food stores under the Biedronka name; and a chain of health and beauty stores under the Hebe banner in Poland, as well as food stores under the Ara name in Colombia. The company also operates supermarkets under the Pingo Doce banner; and cash and carry stores under the Recheio name in Portugal. In addition, it operates restaurants under the Pingo Doce name; Bem-Estar pharmacies; petrol stations; and clothing under Code brand. Further, the company operates kiosks and coffee shops under the Jeronymo name; and chocolates and confectionary retail stores under Hussel name. Additionally, the company engages in human resources top management, real estate management and administration, training, and saline brackish waters aquaculture; wholesale of fruit and vegetables; retail management, consultancy, and logistics activities; the purchase and sale of real estate; growing of crops and farming of animals; retail sale of health and beauty products; manufacture of milk and dairy products; and provision of economic and accounting, business portfolio management, financial, and sea passenger water transport services. It is also involved in the trading and distribution of consumer goods; retail and wholesale of non-food products; other business support service activities; and provision of services in the area of wholesale and retail distribution. The company was founded in 1792 and is headquartered in Lisbon, Portugal. Jerónimo Martins, SGPS, S.A. is a subsidiary of Sociedade Francisco Manuel dos Santos, SGPS, S.E.
Earnings Per Share
As for profitability, J.MARTINS,SGPS has a trailing twelve months EPS of €0.98.
PE Ratio
J.MARTINS,SGPS has a trailing twelve months price to earnings ratio of 23.37. Meaning, the purchaser of the share is investing €23.37 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 24.27%.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on May 16, 2022, the estimated forward annual dividend rate is 0.79 and the estimated forward annual dividend yield is 4.08%.
Yearly Top and Bottom Value
J.MARTINS,SGPS’s stock is valued at €22.90 at 22:20 EST, under its 52-week high of €23.30 and way above its 52-week low of €17.67.
Earnings Before Interest, Taxes, Depreciation, and Amortization
J.MARTINS,SGPS’s EBITDA is 29.66.
Moving Average
J.MARTINS,SGPS’s worth is way higher than its 50-day moving average of €20.17 and way higher than its 200-day moving average of €20.64.
More news about J.MARTINS,SGPS.
4. NAVAMEDIC (NAVA.OL)
9.6% sales growth and 16.31% return on equity
Navamedic ASA, a pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Northern Europe. The company's product portfolio includes prescription and non-prescription pharmaceuticals, as well as medical nutrition products, medical devices, food supplements, and cosmetics. It offers medical nutrition products for various therapeutic areas, including phenylketonuria, homocystinuria, maple syrup urine disease, tyrosinemia, methylmalonic acidemia/propionic acidemia, glutaric aciduria, isovaleric acidemia, and urea cycle disorders, as well as products for glycogen storage diseases and renal diseases, fat metabolism, malnutrition, and ketogenic diet. In addition, the company provides consumer health products consisting of non-prescription drugs and health care products for pain relief, cough and cold, gastro, women's health, and others primarily through pharmacies and drugstores; specialty pharmaceutical products in various therapeutic areas comprising dermatology, wound care, women's health, urology, and obesity; and branded generics, including cardiology products and antibiotics. It sells, markets, and distributes its products to hospitals, patients, and pharmacies. The company was formerly known as Glucomed AS and changed its name to Navamedic ASA in 2004. Navamedic ASA was incorporated in 2002 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, NAVAMEDIC has a trailing twelve months EPS of kr0.45.
PE Ratio
NAVAMEDIC has a trailing twelve months price to earnings ratio of 83.33. Meaning, the purchaser of the share is investing kr83.33 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.31%.
More news about NAVAMEDIC.
